Culper Research vs Cerebras: A Neutral Engineering-Driven View
Cerebras’ alleged electromigration issues hinge on temperature and voltage limits, not total power draw, while thermal variation and BallWire power integrity remain concerns.
Cerebras’ alleged electromigration issues hinge on temperature and voltage limits, not total power draw, while thermal variation and BallWire power integrity remain concerns.
Holy sht, $MRVL is in the final stages of a deal to acquire $LITE. Attempting to vertically integrate the most supply constrained chokepoints… with lasers. Is very big brain if they pull it off and suddenly makes other laser players more strategically valuable. https://t.co/61vfIIsBRw
Has $ADYEN ever not puked on earnings? It feels like one of those $SNAP esque stocks that drops 10% every quarter, steadily climbs back as sentiment recovers just to puke 10% again.
$MRVL for $LITE absolutely meets the test mentioned below. https://t.co/53nmZnoYQ9
*MARVELL IS SAID IN ADVANCED TALKS TO BUY LUMENTUM HOLDINGS What the fuck???? $MRVL $LITE
*MARVELL IS SAID IN ADVANCED TALKS TO BUY LUMENTUM HOLDINGS $LITE
$GEN might actually be a pretty good business https://t.co/5dQEvZFVwa https://t.co/ewNvBnvYV7
$CVNA looks like it's sacrificing loan monetization to drive units. This is a very slippery slope my friends. We've been short this, and 100% wrong, to be transparent and accountable. But the fundamental story looks like its starting to show signs of erosion on the margin.
Cerebras relies on OpenAI for almost all of its $25 billion backlog while renting AI capacity, raising questions over its semiconductor…
Cigna faces PBM margin pressure as employer fee demands and Signature transition costs outweigh specialty-drug growth, limiting profit…
Vertiv beat Q3 revenue guidance by $460 million, grew organic sales 55%, and raised full-year revenue guidance by $650 million to a $14.65…
EQT moved to Distribute at $56.29 after Q3 revenue fell 9.6%; a 44% trailing free-cash-flow margin signals cycle risk despite lower debt…
Innodata shares fell 25% to $44.74 after India Today reported 550 job cuts in India.
GFL’s take-private structure hinges on BC Partners rolling 60% of its stake to preserve debt portability under the 40% permitted-holder…
Lumentum’s 2027 optical-chip expansion, 200G EML and CW capacity, silicon-photonics roadmap, pricing and 3.2T module prospects face…
AST SpaceMobile targets intermittent US satellite service by end-2026 as New Glenn progress could speed constellation launches after…
Neoclouds face tighter debt financing as AI infrastructure capex outruns cash flow, leaving cash-burning GPU providers more exposed than…
Reddit generated $805 million in Q2 2026 revenue, 95% from ads, but slowing Google search referrals expose AI-driven traffic and…
ZTS · long Zoetis, the animal prescription-medicines company, is presented as a long investment despite concerns around its 2026 and 2027 outlook.
Brown & Brown compounded revenue 14.4% annually since 1998 through more than 650 acquisitions, capped by its nearly $10 billion Accession…
Ford’s 1956 IPO sold 10.2 million shares at $63 each after Goldman Sachs helped resolve the Ford Foundation’s voting-rights problem.
Lawrence Hamtil discusses the farmer mentality, software’s cycle and investing with irreplaceable capital.
Sea and Mercado Libre defend Brazilian e-commerce share with logistics, cross-border trade, VIP programs and financial services, accepting…
Infineon’s power semiconductors stand to benefit from AI data centers shifting to 800VDC power delivery, though its sharp rerating to…
Universal Health Services faces a $432 million–$480 million annual Medicaid supplemental-payment hit by 2032, offset by behavioral-health…
Weekly reading list covers Agnico Eagle, Cameco, Dollar Tree, Meta, Braze and Apollo across mining, retail, AI and insurance.
Portfolio update: sold Nomad Foods, trimmed Copart, added Pool Corp and Floor & Decor, and bought Tractor Supply as the portfolio trails…
Ivonescimab plus chemotherapy extended median overall survival by 4.2 months versus Tevimbra plus chemotherapy in HARMONI-6, challenging…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.